WASHINGTON, D.C., January 16, 2026 — The United States and Mexico have been asked to defend their measles elimination status after recent outbreaks prompted concern from international health officials. It’s a stark reminder that even diseases once considered vanquished can resurface, and it begs the question: are we losing ground in the fight against preventable illnesses?
Measles Elimination Status Under Review in U.S. and Mexico
Table of Contents
A regional health body will assess whether recent outbreaks jeopardize decades of progress in eradicating measles in the Americas.
- The Pan American Health Organization (PAHO) will hold virtual meetings with U.S. and Mexican health authorities on April 13, 2026.
- The reviews stem from measles outbreaks that began in the U.S. on January 20, 2025, and in Mexico on February 1, 2025.
- Maintaining high vaccination rates, robust surveillance systems, and swift outbreak responses are crucial to preventing the spread of measles.
The Pan American Health Organization (PAHO) Regional Monitoring and Re-Verification Commission for Measles, Rubella, and Congenital Rubella Syndrome (RVC) issued the invitations to meet. The commission’s scrutiny comes after reported measles outbreaks in both countries. The U.S. outbreak began on January 20, 2025, while Mexico’s started a month later, on February 1, 2025.
Q: What defines a successful measles elimination program?
A: Successful elimination means interrupting the chain of measles virus transmission—specifically, maintaining a continuous, uninterrupted chain of the same genotype and lineage for 12 months or more within a defined geographical area, like a country.
The Commission’s Role and Framework
The RVC operates under the Regional Framework for the Sustainability and Reverification of Measles, Rubella, and Congenital Rubella Syndrome Elimination in the Americas. The commission typically meets annually, but can convene more frequently as needed to fulfill its duties. The upcoming meetings were scheduled to allow national health authorities and committees ample time to prepare detailed reports. These reports will include epidemiological and laboratory evidence for the commission’s review.
The RVC is an independent technical body reporting directly to the PAHO Director. Its core mandate is to monitor and verify the elimination of measles, rubella, and congenital rubella syndrome (CRS) across PAHO Member States. The commission also assesses whether endemic transmission has been reestablished.
The commission’s review process involves examining national reports, epidemiological and laboratory data, molecular evidence, and findings from on-the-ground investigations. Following its assessment, the RVC will submit recommendations to the PAHO Director, who will then determine each country’s official classification and communicate the decision to national authorities.
The Importance of Vaccination and Surveillance
Health officials emphasize that measles outbreaks are fueled by unvaccinated populations. This underscores the importance of consistently high and equitable vaccination coverage, coupled with strong surveillance systems and rapid outbreak response capabilities throughout the region.
The upcoming meetings represent a critical step in evaluating the ongoing efforts to protect the Americas from the resurgence of this preventable disease. The stakes are high, as a lapse in vigilance could undo decades of progress.
